BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

CSL Biotherapies 

P.O. Box 60446
1020 First Avenue
King of Prussia  Pennsylvania  19406  U.S.A.
Phone: 888-4FLU-OFF Fax: n/a


SEARCH JOBS




Industry
Manufacturing

Segment
Vaccines





 Company News
CSL Biotherapies Renamed bioCSL Inc. 2/27/2014 9:53:54 AM    More...
CSL Biotherapies Completes 2013-14 Season AFLURIA® Shipments 9/24/2013 8:55:21 AM    More...
CSL Biotherapies Initiates Shipments of Its Seasonal Influenza Vaccine to U.S. Customers 8/7/2013 8:32:22 AM    More...
CSL Biotherapies Awarded US Government Contract for Influenza Pandemic Preparedness and Response 9/12/2012 10:33:47 AM    More...
CSL Biotherapies Receives US FDA Warning for GMP Violations at Vaccine Plant 6/28/2011 8:39:34 AM    More...
CSL Biotherapies Obtains FDA Licensure for Use of Its Thimerosal-Free Pandemic Influenza A (H1N1) 2009 Monovalent Vaccine in Children 11/12/2009 9:10:48 AM    More...
Merck & Co., Inc. (MRK) (JOBS) Obtains Exclusive U.S. Marketing Rights for AFLURIA(R), Seasonal Influenza Vaccine from CSL Biotherapies 9/28/2009 6:20:59 AM    More...
CSL Biotherapies Announces Start of U.S. H1N1 Vaccine Clinical Trials 8/24/2009 9:21:18 AM    More...
CSL Biotherapies Starts Shipment of Seasonal Influenza Vaccine for the 2009-2010 Flu Season 7/27/2009 8:29:34 AM    More...
CSL Biotherapies Contracts with U.S. Department of Health and Human Services to Provide Novel A (H1N1) Influenza Vaccine Antigen 5/29/2009 8:40:50 AM    More...
12